Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy
E A Grimm, C M Smid, J J Lee, et al.
European Journal of Haematology
|
October 1, 1987
Danazol in the treatment of myelodysplastic syndromes
A C Buzaid, H S Garewal, S M Lippman, et al.
Melanoma Research
|
August 28, 1999
Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10
S Ekmekcioglu, M F Okcu, M I Colome-Grimmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival
S Ekmekcioglu, J Ellerhorst, C M Smid, et al.
Anti-Cancer Drugs
|
November 26, 1999
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
American Journal of Clinical Oncology
|
October 1, 1994
Neuron-specific enolase as a tumor marker in metastatic melanoma
A C Buzaid, A B Sandler, C L Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Role of computed tomography in the staging of primary melanoma
A C Buzaid, A B Sandler, S Mani, et al.
Cancer
|
January 28, 1998
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2
I I Raad, R Y Hachem, D Abi-Said, et al.
The International Journal of Biological Markers
|
October 1, 1994
Correlation between lipid-associated sialic acid and tumor burden in melanoma
A C Buzaid, A B Sandler, C L Hayden, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer
J R Murren, H J Durivage, A C Buzaid, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy
E A Grimm, C M Smid, J J Lee, et al.
European Journal of Haematology
|
October 1, 1987
Danazol in the treatment of myelodysplastic syndromes
A C Buzaid, H S Garewal, S M Lippman, et al.
Melanoma Research
|
August 28, 1999
Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10
S Ekmekcioglu, M F Okcu, M I Colome-Grimmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival
S Ekmekcioglu, J Ellerhorst, C M Smid, et al.
Anti-Cancer Drugs
|
November 26, 1999
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
American Journal of Clinical Oncology
|
October 1, 1994
Neuron-specific enolase as a tumor marker in metastatic melanoma
A C Buzaid, A B Sandler, C L Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Role of computed tomography in the staging of primary melanoma
A C Buzaid, A B Sandler, S Mani, et al.
Cancer
|
January 28, 1998
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2
I I Raad, R Y Hachem, D Abi-Said, et al.
The International Journal of Biological Markers
|
October 1, 1994
Correlation between lipid-associated sialic acid and tumor burden in melanoma
A C Buzaid, A B Sandler, C L Hayden, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer
J R Murren, H J Durivage, A C Buzaid, et al.
Page
of 8